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It is currently known that in CNS the extracellular matrix is involved in synaptic stabilization and limitation of synaptic plasticity.
However, it has been reported that the treatment with chondroitinase following injury allows the formation of new synapses and
increased plasticity and functional recovery. So, we hypothesize that some components of extracellular matrix may modulate
synaptic transmission. To test this hypothesis we evaluated the effects of chondroitin sulphate (CS) on excitatory synaptic
transmission, cellular excitability, and neuronal plasticity using extracellular recordings in the CA1 area of rat hippocampal slices.
CS caused a reversible depression of evoked field excitatory postsynaptic potentials in a concentration-dependent manner. CS
also reduced the population spike amplitude evoked after orthodromic stimulation but not when the population spikes were
antidromically evoked; in this last case a potentiation was observed. CS also enhanced paired-pulse facilitation and long-term
potentiation. Our study provides evidence that CS, a major component of the brain perineuronal net and extracellular matrix, has a
function beyond the structural one, namely, the modulation of synaptic transmission and neuronal plasticity in the hippocampus.
1. Introduction
In the central nervous system the extracellular matrix forms
a compact and organized matrix called perineuronal nets
(PNNs) [1, 2]. The composition of this net is unique and
different from of other tissues. CS proteoglycans (CSPGs)
are the main component of perineuronal nets [3–5] and
consist of a large variety of core proteins covalently linked
to chondroitin sulfate glycosaminoglycans (CS-GAGs) [6].
Astrocytes, neurons, oligodendrocytes, and microglia seem
to synthesize the CSPGs participating in the formation
of perineuronal nets [7]. The role of PNNs is not clear;
it is currently known that they are involved in synaptic
stabilization and limitation of synaptic plasticity [8, 9]. Due
to the negative charge of CS-GAGs, they can bind to various
cations, as sodium, potassium, and calcium, acting as a kind
of buffering system [10–12]. InAlzheimer’s disease, it has been
reported that cortical areas highly rich in perineuronal nets
are less affected by degeneration [13].
After CNS injury, a glial scar is formed [14–16] to
reestablish the integrity of the CNS [17–19]. This enhances
the CS-PGs within the glial scar which remain in the
injured sites for a long period of time [20, 21] whereby
they are considered to inhibit neural regeneration [22, 23].
The inhibitory activity of CS-PGs is mediated mainly by the
CS-GAGs [24]. The molecular mechanisms involved in the
inhibitory effects of CS-GAGs are still not clear. They could
be related to a direct interaction with a CS-GAG receptor
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[25, 26] or through binding to specific growth inhibiting
elements [27]. Alternatively, their effects can be mediated
through the control of CS-GAGs and integrins activation,
although a direct interaction betweenCS-GAGs and integrins
has not been demonstrated [28]. Other studies have shown
that the function of CSPGs may be related to the specific
sulfation sequence of CS chains [29–32] that could act as both
inhibitory molecules for axonal growth and neuritogenic
molecules [18, 32]. In line with this is the observation that
the treatment with chondroitinase following injury allows the
formation of new synapses, increases synaptic plasticity, and
leads to functional recovery [33–36].
On the other hand, some postsynaptic neurotransmitter
receptors are also directly influenced by components of
the extracellular matrix [37]. It has been reported that
the removal of hyaluronic acid from hippocampal slices
suppresses L-type Ca2+ currents and reduces Ca2+ transients
[38].One of the primary events for the induction of long-term
potentiation (LTP) at this synapse is the elevation of post-
synaptic Ca2+ concentrations [39]; so, these molecules may
modulate neuronal plasticity [38]. Thus, the study of the role
of perineuronal net components on synaptic transmission
is important to understand both neuronal excitability and
plasticity [40]. Other studies have also reported that removal
of hyaluronic acid facilitates lateral diffusion of membrane
molecules, including AMPA receptors, and reduces the level
of paired-pulse depression [38, 41]. It is also known that
digestion of CS-PGs with chondroitinase impairs early-LTP
(e-LTP) [42] and mice deficient in the CS-PGs brevican
or neurocan show impaired e-LTP and late-LTP (l-LTP),
respectively [43]. We have recently reported that CS induces
Na+ inward current that causes cell depolarisation and
a transient elevation of the cytosolic Ca2+ concentration
([Ca2+]c) in cultured rat hippocampal neurons; these effects
were selectively mediated by AMPA/kainate receptors [44].
Our present study provides evidence that, in addition
to playing an important role in the structural integrity of
mammalian extracellular matrix, CS can alsomodulate cellu-
lar excitability, synaptic transmission, and neuronal plasticity
in rat hippocampal slices. Thus, CS caused a reversible
depression of synaptic transmission that was not prevented
by an antagonist of kainate receptors. On the other hand,
CS decreased the population spike mediated by synaptic
transmission but enhanced the population spike evoked
antidromically. Additionally, CS exhibited a modulator role
in neuronal plasticity by enhancing both paired-pulse facili-
tation and e-LTP. Our data strongly suggest that not only CS
has a structural function in the CNS but also this GAG has
functional effects, for instance, the modulation of synaptic
transmission.
2. Materials and Methods
2.1. Preparation of Hippocampal Slices. All experiments were
performed on 400 𝜇m thick transverse hippocampal slices
obtained with standard methods from male Sprague-Dawley
rats (200–250 g). The care and use of animals were carried
out in accordance with the National Council on Animal
Care and the European Communities Council Directive and
were approved by the local Animal Care Committee of
UniversidadAuto´nomadeMadrid.Animalswere decapitated
after anaesthesia with isoflurane, and the brain was quickly
removed and dropped into ice-cold Krebs-Ringer bicarbon-
ate (KRB) solution containing (in mM) the following: 119
NaCl, 26.2 NaHCO
3
, 2.5 KCl, 1 KH
2
PO
4
, 1.3 MgSO
4
, 2.5
CaCl
2
, and 11 glucose. This solution was gassed with 95%
O
2
and 5% CO
2
. The hippocampi were sliced with a manual
tissue chopper and placed in an interface holding chamber for
at least 2 h at room temperature (20–25∘C). A single slice was
transferred to a submersion-type recording chamber where it
was continuously superfused (2mL/min) with standard KRB
solution. Bath temperature in the recording chamber was
maintained at 31-32∘C.
2.2. Extracellular Recordings of Evoked Synaptic Potentials.
Synaptic responses were evoked by stimulating the collateral-
commissural fibbers of Schaffer with electrical pulses (20–
50 𝜇A, 100 𝜇s, 0.033–0.066Hz) applied through bipolar tung-
sten insulated microelectrodes placed on CA1 stratum radia-
tum. This stimulating pulse evoked a fEPSP of about 1mV
amplitude that represents the 40–50% of maximal response.
Electrical pulses were supplied by a stimulus isolation unit
(Cibertec, Model ISU200BIP, Madrid, Spain). The field EPSP
and the presynaptic fibber volley (FV) from the stratum
radiatum of the CA1 region were recorded with tungsten
microelectrodes (1MΩ) connected through a home-made
preamplifier to a Grass amplifier (Model 7P511H).
2.3. Electrophysiological Data Analysis. Evoked responses
were low-pass-filtered at 3 kHz and digitized at 25 kHz using
a Digidata 1440A board (Axon Instruments) and stored on
a computer using pCLAMP-10 software (Axon Instruments).
The amplitude of the presynaptic FV was measured from
the baseline to the negative peak of the FV. The synaptic
strength was calculated using the initial slope phase (1ms
window) of the fEPSP to avoid the possible contamination
of the response by propagated population spikes. Field EPSP
slope is considered a fine indicator of glutamatergic synaptic
transmission. As baseline of field potentials we took themean
value of the signal (2–5ms) preceding the stimulus artefact.
We used pCLAMP-10 software for these calculations. Traces
shown are averages of eight consecutive responses. Data were
normalized with respect to the mean values of the responses
at baseline period in standard medium.
2.4. Chemicals. Chondroitin sulfate used in the present
study was provided by Bioibe´rica (Barcelona, Spain). CS
is highly purified chondroitin sulfate of bovine origin in a
concentration above 98% (measured by CPC titration assay,
the official assay method of the USP CS monograph and
European Pharmacopeia to ensure a correct measure of CS
purity and potency); however, an effect due to unknown
components that constitute the remaining 2% cannot be ruled
out. This product from Bioibe´rica consists of a mixture of
CS sulfated in positions 4 (62%), 6 (32%) or unsulfated (6%)
on the N-acetyl-D galactosamine group. The full range of its
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molecular weight is ∼13–16 kDa with an intrinsic viscosity
of ∼0.02–0.06m3/Kg. (RS)-1-(2-Amino-2-carboxyethyl)-3-
(2-carboxybenzyl)pyrimidine-2,4-dione (UBP-296) was sup-
plied by Tocris Bioscience (Bristol, United Kingdom). CS-
4S (cat. number 27042), heparin (cat. number H3393), and
other chemical components for solutions were obtained from
Sigma-Aldrich (Madrid, Spain).
Chondroitinase ABC from Proteus vulgaris (cat. num-
ber C3667, Sigma-Aldrich, Madrid, Spain) was prepared
(50mU/mL) in a modified KRB (50mM sodium acetate as
reaction activator was added).
The drugs were prepared as stock solutions stored frozen
in the dark and diluted to the final concentration in the super-
fusion solution immediately before use. The osmolarity of
the superfusion solutions was tested with a microosmometer
(Advanced Instruments, Model 3MO, Norwood, MA, USA).
2.5. Statistical Analysis. Datawere expressed asmeans± SEM
of the number of slices (𝑛) studied, from at least 3 different
animals. Student’s 𝑡-test was used to determine statistical
differences betweenmeans.The level of statistical significance
between two groups of data was established at 𝑝 < 0.05.
3. Results
3.1. Chondroitin Sulfate Reversibly Reduces Synaptic Efficacy
in Rat Hippocampal Slices. Initially, we determined the effect
of different CS concentrations (from 10−5 to 10−3M) on
glutamatergic synaptic transmission in the hippocampal CA1
area. Only a single concentration of CS was applied to
each individual slice. Once a stable fEPSP baseline was
established for 20min, CS was applied in the perfusion liquid
causing a fast dose-dependent reduction of fEPSP (Figure 1).
When CS was washed out, synaptic responses returned to
baseline values in about 5min (Figure 1(a)).Themagnitude of
depression observed during the last 2min of CS application
was fitted to a sigmoid functionwhich gave an IC
50
of 346 𝜇M
(Figure 1(b)). At the highest concentration of CS (1mM), the
fEPSP showed a maximal depression of 88.7 ± 3.5%. We
selected the concentration of 300𝜇M CS applied for 20min
to perform all subsequent experiments. Figure 1(c) shows the
time-course ofCS effect exerted on synaptic responses evoked
in dentate gyrus. The effects mediated by CS were similar in
both hippocampal regions, that is, CA1 and dentate gyrus.
Changes in the number of axons recruited by electrical
stimulation will elicit changes in the same direction in the
number of synaptic terminals releasing glutamate which,
consequently, will modify synaptic potential size. Hence, we
wondered whether the reduction in fEPSP caused by CS was
due to the decrement of fibres activated by the stimulus in the
presence of this drug. To answer this question, we recorded
the fibber volley (FV) that corresponds to the number of
axons that were firing action potentials synchronously [45].
The application of CS reduced the fEPSP slope (Figures
1(a) and 1(c)) but did not affect significantly FV amplitude
(Figure 1(d)). So, these results revealed that CS-induced
fEPSP decrease was not due to reduction in the number
of recruited axons, representing therefore a reduction in
synaptic efficacy. We have used a commercial form of CS-4S
that did not mimic the effect obtained by CS from Bioibe´rica.
3.2. Chondroitin Sulfate Application Modifies Synaptic Facili-
tation Induced by Paired Pulses. We next attempted to clarify
whether CS-induced fEPSP reduction involves a presynaptic
alteration of release mechanisms that could be detected with
the stimulation paradigm of paired-pulse facilitation (PPF)
[46].
Pairs of synaptic responses were evoked by two stimuli
with an interstimulus interval of 50–250ms applied every 15 s
throughout the experiment.This stimulation pattern induces,
for a short time, an increase in transmitter release resulting
from the residual presynaptic free Ca2+ levels that is more
evident at the shorter stimulus intervals. As shown in Figure 2
CS mainly decreased the first pulse but did not affect the
second fEPSP; therefore, the normalized facilitation ratio
(second pulse/first pulse) changed during CS perfusion at all
intervals evaluated (1.85 ± 0.07, 1.57 ± 0.08, 1.36 ± 0.09, and
1.24 ± 0.07) when compared with control conditions (1.48 ±
0.05, 1.30± 0.07, 1.20± 0.07, and 1.10± 0.10) at 50, 100, 150, and
250ms intervals tested, particularly at the shorter intervals
(𝑝 < 0.01; one-wayANOVA, Figure 2). After CSwashout, the
ratio value returned to control conditions (1.50 ± 0.06, 1.32 ±
0.07, 1.17 ± 0.08, and 1.12 ± 0.08 at 50, 100, 150, and 250ms
intervals). Figure 3 shows the time-course of facilitation of
fEPSP evoked by paired pulses at 50ms intervals and applied
every 15 s. As indicated above, CS (300 𝜇M) induced a partial
reduction of the first fEPSP evoked with no effect on the
second fEPSP. The different effects on both signals induced
an increase of paired-pulse facilitation of 15.63% at 50ms
intervals. CS-induced depression of fEPSP seems to be caused
by decreasing glutamate release probability, as shown by the
results of these paired-pulse experiments.
3.3. Chondroitin Sulfate Enhances Intrinsic Excitability. The
results presented above indicate that CS reduces excitatory
synaptic input to CA1 pyramidal cells, but they do not tell
us how CS affects the pyramidal cell output. To answer this
question we explored how CS affected the population spikes
(PS) in stratum pyramidale, evoked by either the orthodromic
stimulation of stratum radiatum or the antidromic stimula-
tion of stratum alveus (Figure 4). After a period of baseline
recording, CS (300 𝜇M) caused a progressive decrement in
orthodromically induced PS amplitude reaching a minimum
of 36.1 ± 6.7% (2.4 ± 0.3mV in control and 1.31 ± 0.3mV
after 15min of CS application, resp.). After drug washout, PS
amplitude slowly recovered to baseline values (Figure 4(a)).
Interestingly, when the PS was antidromically evoked by
stimulating the stratum alveus, which is formed by axons of
CA1 pyramidal neurons, after a short period of PS depression
(8.21 ± 1.1% at 2–4min of application), CS caused a progres-
sive increment in antidromically induced PS amplitude that
reached amaximumof 110.9± 1.7% (2.35± 0.83mV in control
and 2.77 ± 0.79mV after 15min CS application, resp.). After
CS washout, very low recovery of basal PS amplitude was
observed (Figure 4(b)).
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Figure 1: Chondroitin sulfate (CS) reversibly depresses synaptic transmission in the hippocampal slice. (a) Time-course of fEPSP slope
depression exerted by CS (300 𝜇M) applied during the time indicated by the top horizontal bar. Every dot represents the minute-averaged
fEPSP slope. Note the fast turn-on and turn-off of effects exerted by CS. Insets A and B represent the original traces of fEPSPs in the points
A and B of the time-course curve. (b) Degree of depression caused by each concentration of CS at the end of 20min of perfusion. A single
concentration of CS per slice was tested. Data were fitted to the concentration-response curve. Data represent the mean ± SEM (𝑛 = 4 to
8 slices). (c) Time-course of fEPSP slope in the dentate gyrus measured before, during, and after CS applied during 60min (top horizontal
bar). Inset, original traces taken from points A and B of the time-course curve. (d) Time-course of changes on fibber volley (FV) amplitude
induced by bath application of 300 𝜇M CS for the time indicated by the top horizontal bars. Data were normalized to the mean value of the
control period and expressed as mean ± SEM/min of 8–13 experiments.
Chondroitinase ABC (50mU/mL) was used to cat-
alyze the elimination of disaccharides units from polysac-
charides containing (1–4)-𝛽-D-hexosaminyl and (1–3)-𝛽-D-
glucuronosyl or (1–3)-𝛼-L-iduronosyl linkages [47]; that is,
it acts on chondroitin sulfate. In this set of experiments
we evaluated whether synaptic depression exerted by CS is
due to CS chains or other components of their biologically
derived CS. Under treatment with chondroitinase, CS was
unable to mimic the effects exerted by CS described above.
After a 20minperiod of stable fEPSPbaseline, chondroitinase
treated CS was applied in the perfusion liquid during 50min,
causing no modification of fEPSP (Figure 5(a)).
On the other hand, to study if the effects above reported
are specific for CS, we have tested if heparin modified the
fEPSP. As mentioned before, only a single concentration
of heparin was applied to each individual slice. Once a
stable fEPSP baseline was established for 20min, heparin was
applied in the perfusion liquid during the time indicated
by the top horizontal bar causing a fast dose-dependent
reduction of fEPSP. When heparin was washed out, synap-
tic responses returned to baseline values in about 5min
(Figure 5(b)). At concentration of heparin (100 and 300𝜇M),
the fEPSP showed a maximal depression of 24.8 ± 3%
and 63.7 ± 5%, respectively (𝑛 = 3-4). So, this effect on
synaptic transmission seems to be induced by several types
of glycosaminoglycans.
3.4. The Blockade of Kainate Receptors Did Not Prevent
CS-Induced fEPSP Reduction. In a previous paper we have
reported that CS induces Na+ inward current and that
AMPA/kainate receptor blockers (NBQX and CNQX) fully
inhibited the CS effects, while selective blockers of NMDA
receptors did not [44]. In this context, we hypothesized
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Figure 2: Effect of CS on paired-pulse facilitation (PPF). To examine if CS might affect presynaptic glutamate release, PPF was measured by
calculating the percent facilitation of the second pulse fEPSP over the first pulse (fEPSP
2
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slope). (a) The mean PPF was plotted
as a function of the interpulse interval and fitted by an exponential function. (b) fEPSPs recorded in response to paired stimuli separated
by the indicated interpulse intervals (Δ𝑡) in control (left) and after 20min of CS application (300 𝜇M) (right). The fEPSP amplitude evoked
corresponds to the 40–50% of maximal response. Data are mean ± SEM of 10 slices. ∗𝑝 < 0.05, ∗∗𝑝 < 0.01.
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Figure 3: Presynaptic effect of chondroitin sulfate. (a) Time-course of averaged facilitation of fEPSP evoked by paired pulses at 50ms
intervals and applied every 15 s. Note the facilitation exerted by CS (300 𝜇M) applied during the time indicated by the top horizontal bar.
(b) Representative fEPSPs recorded in response to paired stimuli separated by 50 interpulse intervals in control A and after 20min of CS
(300 𝜇M) application B.The amplitudes evoked correspond to the 40–50% of maximal response. Data are mean ± SEM of 14 slices evaluated.
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Figure 4: Variation in the amplitude of synaptic evoked population spike responses following CS treatment. (a) The time-courses show
average population spike (PS) amplitudes evoked orthodromically by stimulation of stratum radiatum that reveal that CS induces a drastic
depression of their amplitude in a reversible manner. Bottom panels show representative PS taken at the times indicated by the letters A
(control) and B (CS). (b) Time-courses of average PS amplitudes evoked antidromically by stimulation of stratum alveus and how CS was able
to enhance their amplitude in a reversible manner. As indicated above, the original traces show representative population spike taken at the
times indicated by the letters A (control) and B (CS). The graph plots data were normalized to the mean value of the 20min control period
and expressed as mean ± SEM/min (𝑛 = 6–11 slices).
that CS induced the inactivation of AMPA receptors; in this
manner, the fEPSP, recorded later in the stratum radiatum of
CA1, evoked by the electrical stimulation of Schaffer collater-
als, is lower than the signal recorded before CS application.
However, the fEPSPs recorded in our experiments were
mainly mediated by the activation of AMPA receptors. Thus,
the pharmacological blockade of these receptors to prevent
the CS effect described before and so, to demonstrate this
hypothesis, is unlikely.
Next, we sought to elucidate whether kainate receptors
were involved in the CS-induced reduction of fEPSP. To
this end, we bath-applied a selective antagonist of kainate
receptors, UBP-296 [48]. As described before, bath appli-
cation of CS (300 𝜇M, for 20min) caused a reduction in
fEPSP; after 2-3min of drug washout, the fEPSP recovered to
baseline control values. To further evaluate the role of kainate
receptors on the CS effect described here, we applied CS in
the presence of selective blocker of this receptor type, UBP-
296 (30 𝜇M). These antagonists were perfused 20min before
the application of CS (300 𝜇M, for 20min). UBP-296 shortly
reduced fEPSPs by itself (14.9 ± 2.5%) but did not prevent
fEPSP reduction caused by CS (Figure 5, 𝑝 > 0.05 when
compared with the reduction caused by CS alone).
3.5. Chondroitin Sulphate Enhances Induction of LTP. A brief
period of tetanization (100Hz, 1 s) applied to the Schaffer
collateral-commissural fibbers of the CA1 region produced a
robust increase in the strength of synaptic transmission (LTP)
that persisted for at least 60min. As previously indicated,
CS application (300 𝜇M) produced an average depression of
fEPSPs of 23.72± 3.8%; this effect was reversible afterwashout
of the drug. To determine if CS could affect the induction
of LTP, CS was perfused after a stable baseline and high
frequency stimulation (HFS; 100Hz, 1 s) was applied in the
presence of CS. In the slices where LTP was induced in the
absence of CS, there was a sharp increase in fEPSP slope
(150.2 ± 8.7% of baseline measured immediately after tetanic
stimulation) that gradually decreased during the posttetanic
potentiation and remained at 122.6 ± 4.3% of baseline after
60min of HFS. When the tetanic stimulation was applied
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Figure 5: Effects of chondroitinase ABC, heparin, and UBP-296 on synaptic transmission. (a) Time-course of fEPSP slope recorded in the
presence of CS (300𝜇M) treated with chondroitinase during the time indicated by the top horizontal bar. Insets A and B represent the original
traces of fEPSPs in the points A and B of the time-course curve. (b) fEPSP recorded in the presence of heparin (100 𝜇M, close circle; 300 𝜇M,
open circle). Insets represent the original traces in the points A and B of the time-course curve (heparin 300𝜇M). (c) Normalised averaged
depression of fEPSP observed after application of 300𝜇MCS in control slices and others pretreated withUBP-293 (30 𝜇M).The bars represent
themean± SEMof those fEPSPs recorded during the 35minutes of drug application.Note that no statistical differenceswere observed. (𝑛 = 11
slices).
in slices pretreated with CS, a sharp increase in fEPSP slope
was also produced (189.3 ± 11.9% of baseline); this augmented
signal remained at 148.8 ± 11.1% of baseline after 60min of
tetanic pulse application (Figure 6(a)). A comparison of the
means of the fEPSP slopes recorded 5min after the tetanic
stimulus showed a statistically significant increment of the
potentiation showed a statistically significant increment of
the potentiation conditions (𝑝 < 0.05, 𝑛 = 8). However,
comparing the fEPSP slopes recorded at the end of the
posttetanic period (60min) showedno statistically increment
in the final potentiation (122.6 ± 4.3% and 148.8 ± 11.1%
induced in control and CS-pretreated slices). So, we can
conclude that CS potentiates the induction of LTP but it
does not modify its maintenance. When CS was applied after
tetanisation, an enhancement of signal was observed after CS
washout during approximately 15–20min; after this time, as
shown above, no statistical differences were observed when
compared with control (data not shown). This potentiation
after CS application was associated with the nonpermanent
rebound observed after CS washout (increase over baseline).
Figure 6(c) shows a time-course of LTP recording normalized
to the baseline after CS washout, so this rebound was not
considered, and now it is easier to appreciate the fact that CS
enhances the induction of LTP but not its maintenance.
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Figure 6: Chondroitin sulfate enhanced short LTP in hippocampal slices. (a) Averaged time-course in control conditions (circle symbol) and
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4. Discussion
Due to the complexity and heterogeneity of CS, the precise
structure of CS with biological activity and their underlying
molecular mechanisms of action are poorly understood.
In the present work we have studied the effects exerted
by synthetic CS on evoked synaptic transmission, neuronal
excitability, and neuronal plasticity in slices of rat hip-
pocampal neurons. CS caused the following: (i) a reversible
depression of fEPSPs in a concentration-dependent manner;
(ii) a strong blockade of the population spike amplitude when
it was mediated by synaptic transmission but not when it was
antidromically evoked; in this last case a potentiation was
observed; (iii) an enhancement of paired-pulse facilitation
ratio; and (iv) an increase in LTP magnitude. So, our results
provide evidence that CS can modulate neuronal communi-
cation, synaptic transmission, and neuronal plasticity.
4.1. Chondroitin SulphateDepresses Synaptic Transmission and
Alters Neuronal Excitability. In this study we have shown that
CS produces a fast, pronounced, and reversible depression of
fEPSP in a concentration-dependent manner. The molecular
mechanisms involved in the inhibitory effects of CS are not
clear. They could be related to a direct interaction with a
CS-GAG receptor [25, 26]. This depression may be linked to
the capability of CS to modulate the 𝛽-1 integrin pathway.
Recently, some authors have reported that CSPGs restrict
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spine dynamics andmotility through thisway [49]. Curiously,
this integrin is linked to AMPA receptors and so it is involved
in mediating transmission. 𝛽-1 integrin KO mice showed a
drastic reduction in fEPSP at the CA3–CA1 synapse [50]. In
addition, in primary culture of hippocampal neurons we have
recently reported that CS induces Na+-dependent inward
whole-cell current and that blockers of AMPA receptors
inhibited the CS effects; in contrast, the blockade of NMDA
receptors did not modify those effects [44]. With these
considerations, we hypothesize that CS induces a partial
inactivation of AMPA receptors; in this manner, the latter
fEPSP recorded in the stratum radiatum of CA1 evoked by
the electrical stimulation of Schaffer collateral is lower than
the signal recorded before CS application. We noted that CS-
induced fEPSP depression was not due to an effect of CS
on axon recruitment as inferred from the lack of significant
changes observed in the FV amplitude. In spite of these
considerations, we cannot discard that the depression exerted
by CS may also be due to a direct interaction with the
component involved in synaptic transmission or mediated
by inducing an increment in the excitability of hippocampal
interneurons [25]. Additionally, we would like to point out
that some possible discrepancies with other studies may be
linked to the specific sulfation sequence chains used, because
this feature determines the CSPG functions [29–32, 51].
Here we have found that CS mediated the depression
of cellular excitability when population spike was evoked
by orthodromic stimulation of stratum radiatum fibbers,
as expected from the depression of fEPSP elicited by CS.
However, our results also evidenced that CS produced a
potentiation of neuronal excitability when population spikes
were evoked by antidromic stimulation of alveus fibbers, in
other words, when action potential was not mediated by
synaptic transmission. We noticed that this potentiation of
population spikes excitability did not develop epileptogenic-
like behaviour.Themolecularmechanism underlying the CS-
modulation of neuronal excitability is also poorly under-
stood. However, we think that the molecular mechanisms
underlying these effects may be associated with the control of
ions involved in the generation, propagation, and termination
of action potential, as reported in neocortex andhippocampal
slices were CS-GAGs removal shows an increase in the
rate of Ca2+ diffusion [52]. Additionally, this idea is com-
patible with our previous paper where CS produced Na+-
dependent inwardwhole-cell current; such current causes cell
depolarization and [Ca2+]c transient in primary cultures of
hippocampal neurons [44].
4.2. Effects of Chondroitin Sulfate on Neuronal Plasticity. In
spite of CS-induced fEPSP depression, associated with a pos-
sible inactivation of AMPA receptors as indicated above, CS
also modulates the glutamate release probability as inferred
from the significant changes observed with the paired-pulse
facilitation paradigm. This enhancement of facilitation may
be associated with the property of CS to evoke an elevation of
the [Ca2+]c [44, 53].
As a result of this modulation of neuronal transmission,
we have observed that CS also modifies LTP induction. One
of the primary events for induction of LTP is the postsynap-
tic Ca2+ concentration that promotes the incorporation of
additional AMPA receptors into the postsynaptic sites [54].
Additionally, components of the extracellular matrix affect
ligand binding [37], channel kinetics, and Ca2+ permeability
ofAMPAreceptors [54]. Pyramidal cellsmostly expressCa2+-
impermeable AMPA receptors [55, 56]. It has been reported
that CS actions are mediated by its interaction with Ca2+-
impermeable AMPA receptors [44] and that these receptors
mediate excitatory synaptic transmission and play a key role
in hippocampal LTP.
Thus, the neuronal transmission of the majority of
synapses is influenced by extracellular matrix through inter-
actions with their specific receptors. The application of
hyaluronidase in hippocampal slices suppresses L-type cal-
cium currents and reduces Ca2+ transients in postsynaptic
dendrites or spines and abolishes anL-type-mediated compo-
nent of LTP [38]. After removal of hyaluronic acid, the AMPA
receptors diffusion is facilitated and the level of paired-pulse
depression under conditions of elevated release probability
is reduced [38, 41]. It has been reported that chondroitinase
ABC impairs e-LTP [42] and mice deficient in brevican or
neurocan show impaired e-LTP and l-LTP, respectively [43].
4.3. Potential Physiological Role of Chondroitin Sulphate in
the Modulation of Neurotransmission. CS-GAG degradation
opens up spaces for axonal growth and the formation of new
neuronal contacts [57, 58]. In addition to this structural role,
amore pharmacological profile of these degradation products
has been suggested [59]. This may be the case for CS that
modulates synaptic transmission and processes such as LTP.
The biological activity of CS is defined by the sulfation
pattern of repeating disaccharide units [60]. Our CS from
Bioibe´rica consists of highly purified chondroitin sulfate of
bovine origin in a concentration not less than 98%; however,
we cannot discard that the effects here reported may be, at
least in part, due to compounds included in the 2% remain-
ing. Our product consists of a mixture of CS sulfated in posi-
tions 4 (62%), 6 (32%) or unsulfated (6%) on the N-acetyl-D
galactosamine group. Other authors have reported that only
CS with desulfation in the 4 and 6 position of N-acetyl-D
galactosamine group is critical for its biological activity [61].
However, other studies also point out that in spite of the
sulfation in the 6 position ofN-acetyl-D galactosamine group
a 2 position sulfation of glucuronic acid for biological activity
is also necessary [34, 62]. We have also tested a commercial
form of chondroitin with sulfation in the 4 position that did
not mimic the effect obtained by CS from Bioibe´rica.
In conclusion, we have found that in rat hippocampal
slices CS depressed fEPSPs reduced the population spike
amplitude evoked by orthodromic stimulation and aug-
mented paired-pulse facilitation as well as LTP. These data
support the hypothesis that degradation of extracellular
matrix could release free CS that will then exhibit its effects
on enhanced Ca2+ signaling and Ca2+-dependent neuronal
plasticity. This remodeling of perineuronal nets contributes
to brain plasticity and hence to regulating cognition, tissue
repair, cell migration, or axon regrowth [18].
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